Evidence map›Paper›PMID 34836223›Full record

ArticleNutrients2021

Paula Aranaz, Adriana Peña, Ariane Vettorazzi, María José Fabra, Antonio Martínez-Abad, Amparo López-Rubio, Joan Pera, Javier Parladé, Massimo Castellari, Fermín I Milagro and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Anti-Obesity Properties of a Novel Probiotic Strain ofInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Black mulberry (Heliyon · 2025
    Article
  5. Frontiers in nutrition · 2025
    Article
  6. Review
  7. Anti-Obesity Effect ofNutrients · 2023
    Article
  8. Review
  9. Application ofInternational journal of molecular sciences · 2023
    Review
  10. Article
  11. Orientin Prolongs the Longevity ofOxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Paula AranazCenter for Nutrition Research, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1282-0079
Adriana PeñaCenter for Nutrition Research, University of Navarra, 31008 Pamplona, Spain.
Ariane VettorazziDepartment of Pharmacology and Toxicology, MITOX Research Group, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-9182-8417
María José FabraFood Safety and Preservation Department, Institute of Agrochemistry and Food Technology (IATA-CSIC), 46980 Valencia, Spain.ORCID 0000-0001-6726-4455
Antonio Martínez-AbadFood Safety and Preservation Department, Institute of Agrochemistry and Food Technology (IATA-CSIC), 46980 Valencia, Spain.
Amparo López-RubioFood Safety and Preservation Department, Institute of Agrochemistry and Food Technology (IATA-CSIC), 46980 Valencia, Spain.ORCID 0000-0001-6469-9402
Joan PeraInstitute of Agriculture and Food Research and Technology (IRTA), Cabrils Centre, IRTA, Ctra. Cabrils Km. 2, 08348 Barcelona, Spain.ORCID 0000-0002-7252-8205
Javier ParladéInstitute of Agriculture and Food Research and Technology (IRTA), Cabrils Centre, IRTA, Ctra. Cabrils Km. 2, 08348 Barcelona, Spain.
Massimo CastellariInstitute of Agriculture and Food Research and Technology (IRTA), Finca Camps i Armet s/n, 17121 Monells, Spain.ORCID 0000-0002-4952-2358
Fermín I MilagroCenter for Nutrition Research, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-3228-9916
Carlos J González-NavarroCenter for Nutrition Research, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-3517-9077
Consejo Superior de Investigaciones Científicas · ESInstitute of Agrifood Research and Technology · ESUniversidad de Navarra · ESInstituto de Salud Carlos III · ESNavarre Institute of Health Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, food ingredients rich in bioactive compounds have emerged as candidates to prevent excess adiposity and other metabolic complications characteristic of obesity, such as low-grade inflammation and oxidative status. Among them, fungi have gained popularity for their high polysaccharide content and other bioactive components with beneficial activities. Here, we use the

Indexed as

Dietary SupplementsGrifolaLongevityAdipose TissueAgingAnimalsAnti-Obesity AgentsAntioxidantsCaenorhabditis elegansCaenorhabditis elegans ProteinsComplex MixturesDNA-Binding ProteinsForkhead Transcription FactorsLipofuscinNF-E2-Related Factor 2Reactive Oxygen SpeciesAnti-Obesity AgentsAntioxidantsCaenorhabditis elegans ProteinsComplex Mixturesdaf-16 protein, C elegansDNA-Binding ProteinsForkhead Transcription FactorsLipofuscinNF-E2-Related Factor 2Reactive Oxygen Speciesskn-1 protein, C elegansTranscription Factorsbioactive compoundsfood ingredientsinsulinmetabolic syndromenutraceutical fungiobesity

Identifiers

PMID34836223
PMCPMC8620745
OpenAlexW3213185508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.